Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

In recent years, Kessler has lost considerable weight himself with the help of the new GLP-1 drugs. He describes his weight ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Pepsi's slump is mainly due to aggressive price hikes and high T-bond yields, not diworsification or health trends.

Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...

Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...